Amwell: Cost Controls and Margin Gains Offset by Weak Growth Outlook, Justifying a Hold Rating

BTIG analyst David Larsen has maintained their neutral stance on AMWL stock, giving a Hold rating today.

David Larsen has given his Hold rating due to a combination of factors that balance improving execution with weaker growth prospects. Amwell delivered slightly better-than-expected fourth-quarter revenue and a notable EBITDA beat, aided by cost reductions and the mix shift toward higher-margin subscription revenue, and management is guiding to improved cash flow metrics.

At the same time, the company’s 2026 revenue outlook is materially below both BTIG’s prior model and consensus, pointing to another year of top-line contraction and a slower-than-hoped return to growth, with lingering concerns around churn and contract run-off. While the pipeline, key renewals, government opportunities, and a discounted valuation versus peers offer potential upside, Larsen views these positives as offset by the muted growth trajectory, leading him to maintain a neutral, or Hold, stance on AMWL shares.

Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AMWL in relation to earlier this year.